← All Sponsors
SPONSOR

Kexing Biopharm Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Respiratory Syncytial Virus Infections
NCT06363370 Phase 3
Recruiting

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Respiratory Syncytial Virus Infections
China View Trial →